D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 46 Citations 9,216 120 World Ranking 3773 National Ranking 61

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Malaria

John Lusingu mainly investigates Malaria, Plasmodium falciparum, Immunology, RTS,S and Tanzania. His research ties Incidence and Malaria together. His Plasmodium falciparum research is multidisciplinary, incorporating perspectives in Genetics, Receptor, Antibody, Virology and Virulence.

John Lusingu focuses mostly in the field of Virology, narrowing it down to topics relating to Group A and, in certain cases, Gene. He has included themes like Vaccine efficacy and Vaccination in his RTS,S study. His studies examine the connections between Vaccine efficacy and genetics, as well as such issues in Pediatrics, with regards to Randomized controlled trial and Adverse effect.

His most cited work include:

  • First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. (684 citations)
  • Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure (374 citations)
  • National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010 (370 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Malaria, Plasmodium falciparum, Immunology, Virology and Tanzania. He does research in Malaria, focusing on Malaria vaccine specifically. His Malaria vaccine study deals with Vaccination intersecting with Circumsporozoite protein.

His work carried out in the field of Plasmodium falciparum brings together such families of science as Antibody, Gene, Pathogenesis and Antigen. Parasite load is closely connected to Disease in his research, which is encompassed under the umbrella topic of Immunology. John Lusingu works mostly in the field of Virology, limiting it down to topics relating to Antigenic variation and, in certain cases, Clone.

He most often published in these fields:

  • Malaria (104.24%)
  • Plasmodium falciparum (84.24%)
  • Immunology (49.09%)

What were the highlights of his more recent work (between 2017-2021)?

  • Malaria (104.24%)
  • Plasmodium falciparum (84.24%)
  • Pregnancy (32.12%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Malaria, Plasmodium falciparum, Pregnancy, Obstetrics and Tanzania. His Malaria study focuses on Cerebral Malaria in particular. His Plasmodium falciparum research incorporates elements of Immune system, Antibody, Cell biology, Endothelium and Microcirculation.

When carried out as part of a general Pregnancy research project, his work on Gestational age, Birth weight, Full Term and Placental dysfunction is frequently linked to work in Low resource, therefore connecting diverse disciplines of study. John Lusingu interconnects Cohort study, Iron deficiency, Public health, Intrauterine growth restriction and Cohort in the investigation of issues within Obstetrics. His RTS,S research includes elements of Incidence and Vaccine efficacy.

Between 2017 and 2021, his most popular works were:

  • The Prevotella copri Complex Comprises Four Distinct Clades Underrepresented in Westernized Populations (82 citations)
  • Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial. (19 citations)
  • Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial. (19 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Malaria

His primary scientific interests are in Malaria, Cerebral Malaria, Plasmodium falciparum, Genotype and Disease. John Lusingu works on Malaria which deals in particular with RTS,S. His research in Cerebral Malaria intersects with topics in Antibody, Pediatrics and Virology.

His Plasmodium falciparum research is multidisciplinary, relying on both Immunoglobulin G, Antiserum, Immune system and Antigen. His work deals with themes such as Parasite load, Anemia and Immunology, which intersect with Genotype. His research integrates issues of Meningitis and Malaria vaccine in his study of Randomized controlled trial.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;Solange Solmeheim Soulanoudjingar;Solange Solmeheim Soulanoudjingar.
The New England Journal of Medicine (2011)

1107 Citations

National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010

Anne C.C. Lee;Anne C.C. Lee;Joanne Katz;Hannah Blencowe;Simon Cousens.
The Lancet Global Health (2013)

698 Citations

Severe malaria is associated with parasite binding to endothelial protein C receptor

Louise Turner;Thomas Lavstsen;Sanne S. Berger;Christian W. Wang.
Nature (2013)

537 Citations

Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure

C. J. Drakeley;P. H. Corran;P. G. Coleman;J. E. Tongren.
Proceedings of the National Academy of Sciences of the United States of America (2005)

533 Citations

Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age

Philip Bejon;John Lusingu;Ally Olotu;Amanda Leach.
The New England Journal of Medicine (2008)

522 Citations

Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes.

Anja T.R. Jensen;Pamela Magistrado;Sarah Sharp;Louise Joergensen.
Journal of Experimental Medicine (2004)

354 Citations

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

Daniel E Neafsey;Michal Juraska;Trevor Bedford;David Benkeser.
The New England Journal of Medicine (2015)

338 Citations

Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children

Thomas Lavstsen;Louise Turner;Fredy Saguti;Pamela Magistrado;Pamela Magistrado.
Proceedings of the National Academy of Sciences of the United States of America (2012)

280 Citations

Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21 st standard: Analysis of CHERG datasets

Anne C.C. Lee;Anne C.C. Lee;Naoko Kozuki;Naoko Kozuki;Simon Cousens;Gretchen A. Stevens.
BMJ (2017)

263 Citations

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Michael T. White;Robert Verity;Jamie T. Griffin;Kwaku Poku Asante.
Lancet Infectious Diseases (2015)

252 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John Lusingu

Chris Drakeley

Chris Drakeley

London School of Hygiene & Tropical Medicine

Publications: 138

James G. Beeson

James G. Beeson

Burnet Institute

Publications: 126

Teun Bousema

Teun Bousema

Radboud University Nijmegen

Publications: 85

Ivo Mueller

Ivo Mueller

Walter and Eliza Hall Institute of Medical Research

Publications: 79

Philippe Deloron

Philippe Deloron

Université Paris Cité

Publications: 76

Thor G. Theander

Thor G. Theander

University of Copenhagen

Publications: 75

Kevin Marsh

Kevin Marsh

University of Oxford

Publications: 74

Ali Salanti

Ali Salanti

Copenhagen University Hospital

Publications: 62

Joseph D. Smith

Joseph D. Smith

University of Washington

Publications: 59

Lars Hviid

Lars Hviid

University of Copenhagen

Publications: 58

Robert W. Sauerwein

Robert W. Sauerwein

Radboud University Nijmegen

Publications: 52

Freya J. I. Fowkes

Freya J. I. Fowkes

Burnet Institute

Publications: 51

Philip Bejon

Philip Bejon

University of Oxford

Publications: 49

Eleanor M. Riley

Eleanor M. Riley

London School of Hygiene & Tropical Medicine

Publications: 47

Stephen J. Rogerson

Stephen J. Rogerson

University of Melbourne

Publications: 44

Thomas J. Smith

Thomas J. Smith

Johns Hopkins University School of Medicine

Publications: 42

Trending Scientists

Shi-Ping Yan

Shi-Ping Yan

Nankai University

Minghua Liu

Minghua Liu

Chinese Academy of Sciences

Junfa Zhu

Junfa Zhu

University of Science and Technology of China

Paolo Caliceti

Paolo Caliceti

University of Padua

Lee J. Richter

Lee J. Richter

National Institute of Standards and Technology

Seiamak Bahram

Seiamak Bahram

University of Strasbourg

Mathieu Joron

Mathieu Joron

University of Montpellier

Henrik Semb

Henrik Semb

University of Copenhagen

Mark Henkemeyer

Mark Henkemeyer

The University of Texas Southwestern Medical Center

Chris Segrin

Chris Segrin

University of Arizona

James M. Kauffman

James M. Kauffman

University of Virginia

Hossein Gharib

Hossein Gharib

Mayo Clinic

Steven C. Cramer

Steven C. Cramer

University of California, Los Angeles

Christian Lengeler

Christian Lengeler

University of Basel

Huub van den Bergh

Huub van den Bergh

Utrecht University

Moira Jardine

Moira Jardine

University of St Andrews

Something went wrong. Please try again later.